Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
María Luisa Antelo, Natalia de las Heras, Jose Ramón Gonzalez Porras, Ana Kerguelen & Jose María Raya. (2015) Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide. Expert Review of Hematology 8:6, pages 819-835.
Read now
Read now
Gunnar Birgegård. (2013) Pharmacological management of essential thrombocythemia. Expert Opinion on Pharmacotherapy 14:10, pages 1295-1306.
Read now
Read now
Richard T Silver, Jean-Jacques Kiladjian & Hans Carl Hasselbalch. (2013) Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis. Expert Review of Hematology 6:1, pages 49-58.
Read now
Read now
Hans Carl Hasselbalch. (2011) A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Expert Review of Hematology 4:6, pages 637-655.
Read now
Read now
Alessandro M Vannucchi, Paola Guglielmelli, Lisa Pieri, Elisabetta Antonioli & Alberto Bosi. (2009) Treatment options for essential thrombocythemia and polycythemia vera. Expert Review of Hematology 2:1, pages 41-55.
Read now
Read now
Ashkan Emadi & Jerry L Spivak. (2009) Anagrelide: 20 years later. Expert Review of Anticancer Therapy 9:1, pages 37-50.
Read now
Read now
Naseema Gangat & Ayalew Tefferi. (2008) Pharmacotherapy of essential thrombocythemia. Expert Opinion on Pharmacotherapy 9:10, pages 1679-1685.
Read now
Read now
Uwe Platzbecker, Ted Gooley, Claudio Anasetti, Frederick R. Appelbaum, Bruce Clurman, Kris Doney, Thomas Chauncey, Mary E.D. Flowers, David Myerson, Jerald P. Radich, Rainer Storb, Robert P. Witherspoon & H. Joachim Deeg. (2002) Curative Therapy of Advanced Essential Thrombocythemia or Polycythemia Vera by Hemopoietic Stem Cell Transplantation. Leukemia & Lymphoma 43:7, pages 1409-1414.
Read now
Read now
Borje S. Andersson. (2002) Essential Thrombocythemia: Diagnosis and Treatment, with Special Emphasis on the Use of Anagrelide. Hematology 7:3, pages 173-177.
Read now
Read now
Apostolia-Maria Tsimberidou & Francis J. Giles. (2002) Essential Thrombocythemia (ET): Moving from Palliation to Cure. Hematology 7:6, pages 315-323.
Read now
Read now
Tiziano Barbui, Guido Finazzi & Thomas C. Pearson. (1997) The Management of Essential Thrombocythaemia. Hematology 2:2, pages 91-100.
Read now
Read now
Articles from other publishers (43)
Mohammad Abu-Tineh, Nancy Kassem, Mohammad Abdul-Jaber Abdulla, Omar Mohammad Ismail, Rola Ghasoub, Mahmood B. Aldapt & Mohamed A. Yassin. (2020) Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar. Case Reports in Oncology 13:1, pages 336-340.
Crossref
Crossref
Ivy Altomare & Craig M. Kessler. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
346
373
.
Hans Carl Hasselbalch & Morten Orebo Holmström. (2018) Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?. Seminars in Immunopathology 41:1, pages 5-19.
Crossref
Crossref
Prajwal Boddu, Lorenzo Falchi, Chitra Hosing, Kate Newberry, Prithviraj Bose & Srdan Verstovsek. (2017) The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review. Leukemia Research 58, pages 14-22.
Crossref
Crossref
Rodney J. Y. Ho & Milo Gibaldi. 2013. Biotechnology and Biopharmaceuticals. Biotechnology and Biopharmaceuticals
251
305
.
M. Cheminant & R. Delarue. (2013) Prise en charge diagnostique et th?rapeutique d?un patient porteur d?une thrombocytose. La Revue de M?decine Interne 34:8, pages 465-471.
Crossref
Crossref
Gemma Ramirez, Ricarda García-Sanchez & Sylvia Plaza. (2013) Tratamiento del paciente con trombocitemia esencial. Medicina Clínica 140:6, pages 278-282.
Crossref
Crossref
Jamie Koprivnikar & Craig M. Kessler. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
298
323
.
John T. Reilly. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
155
168
.
Tiziano Barbui, Maria Chiara Finazzi & Guido Finazzi. (2012) Front-line therapy in polycythemia vera and essential thrombocythemia. Blood Reviews 26:5, pages 205-211.
Crossref
Crossref
G Finazzi. (2011) How to manage essential thrombocythemia. Leukemia 26:5, pages 875-882.
Crossref
Crossref
Tiziano Barbui. 2012. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms
93
104
.
Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse & Hans Carl Hasselbalch. (2011) Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis. European Journal of Haematology 87:1, pages 54-60.
Crossref
Crossref
Hans Carl Hasselbalch, Jean-Jacques Kiladjian & Richard T. Silver. (2011) Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Journal of Clinical Oncology 29:18, pages e564-e565.
Crossref
Crossref
Suzita M. Noor, Richard Bell & Alister C. Ward. (2011) Shooting the messenger: Targeting signal transduction pathways in leukemia and related disorders. Critical Reviews in Oncology/Hematology 78:1, pages 33-44.
Crossref
Crossref
Christina S. Han, Michael J. Paidas & Charles J. Lockwood. 2011. High Risk Pregnancy. High Risk Pregnancy
739
752.e5
.
Guido Finazzi & Tiziano Barbui. 2011. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms
97
115
.
Claire N. Harrison, David Bareford, Nauman Butt, Peter Campbell, Eibhlean Conneally, Mark Drummond, Wendy Erber, Tamara Everington, Anthony R. Green, Georgina W. Hall, Beverley J. Hunt, Christopher A. Ludlam, Richard Murrin, Catherine Nelson-Piercy, Deepti H. Radia, John T. Reilly, Jon Van der Walt, Bridget Wilkins & Mary F. McMullin. (2010) Guideline for investigation and management of adults and children presenting with a thrombocytosis. British Journal of Haematology 149:3, pages 352-375.
Crossref
Crossref
Graeme McDonald. (2009) Myeloproliferative disorder therapy: assessment and management of adverse events-a psychiatrist's perspective. Hematological Oncology 27:S1, pages 14-16.
Crossref
Crossref
Hans Carl Hasselbalch. (2009) Myelofibrosis with myeloid metaplasia: The advanced phase of an untreated disseminated hematological cancer. Leukemia Research 33:1, pages 11-18.
Crossref
Crossref
Gunnar Birgegård. (2008) Long-term management of thrombocytosis in essential thrombocythaemia. Annals of Hematology 88:1, pages 1-10.
Crossref
Crossref
J-J Kiladjian, C Chomienne & P Fenaux. (2008) Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms. Leukemia 22:11, pages 1990-1998.
Crossref
Crossref
G Finazzi & T Barbui. (2008) Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia 22:8, pages 1494-1502.
Crossref
Crossref
Guido Finazzi & Tiziano Barbui. (2007) Expertise-Based Management in Essential Thrombocythemia and Polycythemia Vera. The Cancer Journal 13:6, pages 372-376.
Crossref
Crossref
István Szegedi, Ilona Benkő, Gabriella Merő, Ágota Prinzinger, János Kappelmayer & Csongor Kiss. (2006) Long‐lasting partial remission by Interferon‐alpha treatment in a child with essential thrombocythemia. Pediatric Blood & Cancer 49:5, pages 744-747.
Crossref
Crossref
Guido Finazzi & Tiziano Barbui. 2007. Myeloproliferative Disorders. Myeloproliferative Disorders
107
124
.
Martin Griesshammer. (2007) Options in the management of essential thrombocythaemia. European Journal of Haematology 79:s68, pages 35-39.
Crossref
Crossref
Craig M. Kessler & Jan Jacques Michiels. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
295
318
.
Jan Samuelsson, Hans Hasselbalch, Oystein Bruserud, Snezana Temerinac, Yvonne Brandberg, Mats Merup, Olle Linder, Magnus Bjorkholm, Heike L. Pahl & Gunnar Birgegard. (2006) A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemia. Cancer 106:11, pages 2397-2405.
Crossref
Crossref
Elisabeth I Penninga & Ole W Bjerrum. (2006) Polycythaemia Vera and Essential Thrombocythaemia. Drugs 66:17, pages 2173-2187.
Crossref
Crossref
U. Schuler & G. Ehninger. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
2749
2775
.
Guido Finazzi & Claire Harrison. (2005) Essential Thrombocythemia. Seminars in Hematology 42:4, pages 230-238.
Crossref
Crossref
Guido Finazzi & Tiziano Barbui. (2005) Risk-adapted therapy in essential thrombocythemia and polycythemia vera. Blood Reviews 19:5, pages 243-252.
Crossref
Crossref
Rashid Saba, Elias Jabbour, Francis Giles, Jorge Cortes, Moshe Talpaz, Susan O'Brien, Emil J. Freireich, Guillermo Garcia‐Manero, Hagop Kantarjian & Srdan Verstovsek. (2005) Interferon α therapy for patients with essential thrombocythemia. Cancer 103:12, pages 2551-2557.
Crossref
Crossref
Jerry L. Spivak, Giovanni Barosi, Gianni Tognoni, Tiziano Barbui, Guido Finazzi, Roberto Marchioli & Monia Marchetti. (2003) Chronic Myeloproliferative Disorders. Hematology 2003:1, pages 200-224.
Crossref
Crossref
L. Lacotte-Thierry & F. Guilhot. (2002) Interféron et hématologie. La Revue de Médecine Interne 23, pages 481S-488S.
Crossref
Crossref
Tiziano Barbui. (2002) What is the standard treatment in essential thrombocythemia. International Journal of Hematology 76:S2, pages 311-317.
Crossref
Crossref
Daniela Matei, Benjamin Brenner & Victor J. Marder. (2001) Acquired thrombophilic syndromes. Blood Reviews 15:1, pages 31-48.
Crossref
Crossref
M. Jurado, H. J. Deeg, T. Gooley, C. Anasetti, T. Chauncey, M. E. D. Flowers, D. Myerson, R. Storb & F. R. Appelbaum. (2001) Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia. British Journal of Haematology 112:2, pages 392-396.
Crossref
Crossref
Guido Finazzi, Marco Ruggeri, Francesco Rodeghiero & Tiziano Barbui. (2001) Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long‐term follow‐up of a randomized clinical trial. British Journal of Haematology 110:3, pages 577-583.
Crossref
Crossref
Pier Mannuccio Mannucci. (2000) Few platelets, many platelets: the role of the internist. European Journal of Internal Medicine 11:1, pages 4-8.
Crossref
Crossref
Jan Jacques Michiels. (2016) Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia. Clinical and Applied Thrombosis/Hemostasis 5:4, pages 247-251.
Crossref
Crossref
Ayalew Tefferi & Murray N. Silverstein. (1998) 4 Treatment of polycythaemia vera and essential thrombocythaemia. Bailli?re's Clinical Haematology 11:4, pages 769-785.
Crossref
Crossref